[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371357-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371357-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinical-prediction-tools-for-patient-reported-outcomes-in-gastrointestinal-cancer-a-scoping-review-protocol","Clinical prediction tools for patient-reported outcomes in gastrointestinal cancer - a scoping review protocol","","Background: Gastrointestinal (GI) cancers contribute substantially to global cancer burden, producing physical and emotional distress. Effective management of patient-reported outcomes (PROs) is crucial for improving quality of life and overall survival, yet clinical tools predicting PROs in GI cancer remain insufficiently explored. This scoping review protocol will identify existing tools, predictors, outcomes, and assess clinical usability and equity considerations. Methods: Using JBI and Arksey–O’Malley scoping review frameworks, studies will include adults with primary GI cancer developing or validating PRO or quality-of-life prediction tools using self-reported PRO measures.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-prediction-tools-for-patient-reported-outcomes-in-gastrointestinal-cancer-a-scoping-review-protocol/371357/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-prediction-tools-for-patient-reported-outcomes-in-gastrointestinal-cancer-a-scoping-review-protocol/371357.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of this scoping review protocol?","Question",{"text":63,"@type":64},"It aims to explore clinical prediction tools for patient-reported outcomes (PROs) and quality of life in patients with gastrointestinal cancer, identifying current tools, predictors, and outcomes and evaluating usability and equity considerations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What study types and patient population will be included?",{"text":68,"@type":64},"The review will include studies of adult patients with primary gastrointestinal cancer that developed or validated clinical prediction tools for PROs or quality of life, using self-reported PRO measures.",{"name":70,"@type":61,"acceptedAnswer":71},"How will the literature be searched and study data extracted?",{"text":72,"@type":64},"A systematic search of Ovid Medline, Embase, and CINAHL will be conducted from 1946 to 2024, with periodic updates and hand-searching references. Data extraction will focus on tool characteristics, predictors, statistical methods, and equity considerations.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371357,1790642412,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Open access Protocol  \nTo cite: Zhu A, Ip KY, Mahar A, et al. Clinical prediction tools for patient-reported outcomes in gastrointestinal cancer: a scoping review protocol. BMJ Open 2025;15:e097966 . doi:10 . 1136/ bmjopen-2024-097966  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2024-097966](bmjopen-2024-097966)) .  \nReceived 13 December 2024 Accepted 10 March 2025  \n© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Natalie G Coburn;  \n[Natalie.Coburn@sunnybrook.ca](Natalie.Coburn@sunnybrook.ca)  \nClinical prediction tools for patientreported outcomes in gastrointestinal cancer: a scoping review protocol  \nAlice Zhu  ,1,2 Ka Yan Ip,3 Alyson Mahar,2,4 Amy T Hsu  ,2,5,6 Paul D James,7 Ekaterina Kosyachkova,8 Teresa Tiano,8 Julie Hallet,1,2,3,9 Natalie G Coburn1,2,3,9  \nABSTRACT  \nBackground Gastrointestinal (GI) cancers are among the most significant contributors to the global cancer burden, causing substantial physical and emotional distress. Effective management of patient-reported outcomes (PROs) is essential for enhancing quality of life and overall survival in cancer care. Despite significant advances in cancer care, understanding PROs and their integration into clinical practice remains limited. Prediction models for PROs have the potential to support patient-centred care by improving shared decision-making and informing care plans. However, the development and application of clinical tools that predict PROs in patients with GI cancer have not been systematically explored. This scoping review aims to explore clinical prediction tools for PROs and the quality of life in patients with GI cancer, identifying current tools, predictors and outcomes, as well as evaluating their clinical usability and equity considerations.  \nMethods and analysis A scoping review methodology, guided by the JBI Manual for Evidence Synthesis and the Arksey and O’Malley framework, will be used. The review will include studies of adult patients with primary GI cancer that developed or validated clinical prediction tools for PROs or quality of life. Inclusion criteria require the use of self-reported PRO measures. A systematic search of Ovid Medline, Embase and CINAHL will be conducted from 1946 to 2024. The search strategy will be updated periodically to incorporate the most recent literature and complemented by hand-searching references. Data extraction will focus on tool characteristics, predictors, statistical methods and equity considerations. The findings will be synthesised descriptively, mapping trends, identifying gaps and highlighting areas for future research. Ethics and dissemination Ethical approval is not required for this literature-based study. Results will be disseminated through peer-reviewed publications, conferences and patient advocacy networks to maximise the impact on research, policy and clinical practice.  \nBACKGROUND  \nCancer poses a significant burden on global health. Gastrointestinal (GI) cancers account for 26% of the global cancer incidence and 35% of all cancer-related deaths.1 Cancer diagnosis and treatment can cause significant physical and emotional distress,2 which, if not appropriately addressed, can lead to  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ Rigorous and comprehensive approach: This approach employs systematic search methods and established frameworks (JBI and TRIPOD) to ensure transparency and replicability, alongside a broad search strategy spanning multiple databases to enhance the review’s depth and diversity of findings.  \n⇒ Patient-centred: The direct involvement of patient partners and healthcare providers ensures the relevance and","cbCailuJGFIFR0wT","https://ap.wps.com/l/cbCailuJGFIFR0wT","pdf",264480,"English","# Abstract\n# Background\n# Methods and analysis\n# Ethics and dissemination\n# Strengths and limitations of this study","[{\"question\":\"What is the purpose of this scoping review protocol?\",\"answer\":\"It aims to explore clinical prediction tools for patient-reported outcomes (PROs) and quality of life in patients with gastrointestinal cancer, identifying current tools, predictors, and outcomes and evaluating usability and equity considerations.\"},{\"question\":\"What study types and patient population will be included?\",\"answer\":\"The review will include studies of adult patients with primary gastrointestinal cancer that developed or validated clinical prediction tools for PROs or quality of life, using self-reported PRO measures.\"},{\"question\":\"How will the literature be searched and study data extracted?\",\"answer\":\"A systematic search of Ovid Medline, Embase, and CINAHL will be conducted from 1946 to 2024, with periodic updates and hand-searching references. Data extraction will focus on tool characteristics, predictors, statistical methods, and equity considerations.\"}]","Clinical prediction tools for patient-reported outcomes in gastrointestinal cancer - a scoping review protocol | PDF",1790191884,15,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e69e4203b2a75679ebb60997e873c704.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c881e9df3f8bd47f4e4d63d11b0d04e.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/849f09f5537cf61b6faffc6ced7d06f7.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4bfa0731f69a31eb6f1076f484f0f886.webp",980,1306]